Coherus BioSciences Inc
NASDAQ:CHRS
Income Statement
Earnings Waterfall
Coherus BioSciences Inc
Revenue
|
257.2m
USD
|
Cost of Revenue
|
-159m
USD
|
Gross Profit
|
98.3m
USD
|
Operating Expenses
|
-296.6m
USD
|
Operating Income
|
-198.3m
USD
|
Other Expenses
|
-39.6m
USD
|
Net Income
|
-237.9m
USD
|
Income Statement
Coherus BioSciences Inc
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
3
N/A
|
6
+115%
|
10
+78%
|
26
+151%
|
31
+20%
|
33
+7%
|
35
+6%
|
26
-25%
|
30
+14%
|
37
+22%
|
44
+20%
|
200
+354%
|
190
-5%
|
178
-6%
|
165
-7%
|
2
-99%
|
2
-33%
|
1
-13%
|
0
N/A
|
0
N/A
|
0
N/A
|
37
N/A
|
121
+225%
|
232
+93%
|
356
+53%
|
435
+22%
|
488
+12%
|
489
+0%
|
476
-3%
|
443
-7%
|
395
-11%
|
364
-8%
|
327
-10%
|
304
-7%
|
276
-9%
|
239
-13%
|
211
-12%
|
183
-13%
|
182
-1%
|
211
+16%
|
257
+22%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(3)
|
(9)
|
(17)
|
(22)
|
(31)
|
(34)
|
(38)
|
(38)
|
(45)
|
(57)
|
(58)
|
(60)
|
(54)
|
(68)
|
(70)
|
(78)
|
(91)
|
(89)
|
(159)
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
35
N/A
|
118
+237%
|
223
+89%
|
339
+52%
|
413
+22%
|
456
+10%
|
456
0%
|
438
-4%
|
404
-8%
|
350
-14%
|
306
-12%
|
269
-12%
|
244
-9%
|
222
-9%
|
171
-23%
|
141
-18%
|
106
-25%
|
91
-14%
|
123
+35%
|
98
-20%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(39)
|
(46)
|
(59)
|
(75)
|
(96)
|
(121)
|
(164)
|
(220)
|
(249)
|
(283)
|
(294)
|
(294)
|
(306)
|
(302)
|
(283)
|
(262)
|
(234)
|
(203)
|
(190)
|
(190)
|
(204)
|
(214)
|
(224)
|
(221)
|
(231)
|
(248)
|
(253)
|
(271)
|
(282)
|
(456)
|
(491)
|
(514)
|
(533)
|
(422)
|
(419)
|
(416)
|
(398)
|
(345)
|
(320)
|
(303)
|
(297)
|
|
Selling, General & Administrative |
(8)
|
(10)
|
(12)
|
(14)
|
(18)
|
(20)
|
(25)
|
(31)
|
(36)
|
(41)
|
(44)
|
(47)
|
(52)
|
(59)
|
(71)
|
(72)
|
(71)
|
(69)
|
(64)
|
(75)
|
(94)
|
(110)
|
(128)
|
(135)
|
(137)
|
(140)
|
(137)
|
(138)
|
(139)
|
(143)
|
(149)
|
(157)
|
(170)
|
(179)
|
(190)
|
(195)
|
(199)
|
(198)
|
(191)
|
(195)
|
(191)
|
|
Research & Development |
(31)
|
(37)
|
(47)
|
(61)
|
(78)
|
(101)
|
(139)
|
(189)
|
(213)
|
(242)
|
(250)
|
(247)
|
(254)
|
(243)
|
(212)
|
(190)
|
(162)
|
(134)
|
(126)
|
(115)
|
(110)
|
(104)
|
(96)
|
(86)
|
(94)
|
(109)
|
(116)
|
(133)
|
(143)
|
(313)
|
(342)
|
(357)
|
(363)
|
(243)
|
(229)
|
(221)
|
(199)
|
(147)
|
(129)
|
(109)
|
(106)
|
|
Operating Income |
(36)
N/A
|
(40)
-12%
|
(49)
-21%
|
(49)
+1%
|
(65)
-33%
|
(88)
-35%
|
(129)
-47%
|
(193)
-50%
|
(219)
-13%
|
(247)
-13%
|
(251)
-2%
|
(95)
+62%
|
(116)
-22%
|
(124)
-7%
|
(118)
+5%
|
(259)
-120%
|
(232)
+10%
|
(202)
+13%
|
(190)
+6%
|
(190)
0%
|
(204)
-7%
|
(179)
+12%
|
(107)
+40%
|
2
N/A
|
108
+4 800%
|
165
+53%
|
203
+23%
|
185
-9%
|
156
-15%
|
(52)
N/A
|
(142)
-172%
|
(208)
-47%
|
(264)
-27%
|
(177)
+33%
|
(197)
-11%
|
(245)
-24%
|
(257)
-5%
|
(239)
+7%
|
(229)
+4%
|
(181)
+21%
|
(198)
-10%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(5)
|
(8)
|
(9)
|
(7)
|
(4)
|
(1)
|
0
|
0
|
0
|
(1)
|
(3)
|
(6)
|
(8)
|
(10)
|
(10)
|
(10)
|
(10)
|
(10)
|
(10)
|
(10)
|
(10)
|
(11)
|
(13)
|
(16)
|
(18)
|
(18)
|
(19)
|
(20)
|
(21)
|
(22)
|
(23)
|
(23)
|
(23)
|
(26)
|
(27)
|
(29)
|
(33)
|
(33)
|
(37)
|
(39)
|
(41)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(6)
|
(6)
|
(6)
|
(6)
|
(5)
|
(5)
|
(5)
|
(5)
|
|
Total Other Income |
(12)
|
(22)
|
(28)
|
(17)
|
(19)
|
(14)
|
(8)
|
(7)
|
(5)
|
(1)
|
(6)
|
(4)
|
(4)
|
(4)
|
5
|
4
|
3
|
4
|
4
|
4
|
5
|
5
|
2
|
2
|
3
|
2
|
2
|
1
|
1
|
1
|
0
|
0
|
(0)
|
(0)
|
0
|
1
|
4
|
5
|
7
|
8
|
5
|
|
Pre-Tax Income |
(54)
N/A
|
(70)
-30%
|
(86)
-23%
|
(73)
+16%
|
(87)
-20%
|
(103)
-18%
|
(137)
-33%
|
(200)
-47%
|
(224)
-12%
|
(249)
-11%
|
(260)
-5%
|
(105)
+60%
|
(128)
-22%
|
(137)
-7%
|
(122)
+11%
|
(265)
-117%
|
(238)
+10%
|
(208)
+13%
|
(196)
+6%
|
(196)
+0%
|
(209)
-7%
|
(185)
+12%
|
(118)
+36%
|
(11)
+91%
|
93
N/A
|
149
+61%
|
186
+25%
|
166
-11%
|
136
-18%
|
(74)
N/A
|
(164)
-122%
|
(231)
-41%
|
(287)
-25%
|
(210)
+27%
|
(231)
-10%
|
(279)
-21%
|
(292)
-5%
|
(272)
+7%
|
(264)
+3%
|
(218)
+18%
|
(238)
-10%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(3)
|
(4)
|
(5)
|
(4)
|
(4)
|
(3)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(54)
|
(70)
|
(86)
|
(73)
|
(87)
|
(103)
|
(137)
|
(200)
|
(224)
|
(249)
|
(260)
|
(105)
|
(128)
|
(137)
|
(122)
|
(265)
|
(238)
|
(208)
|
(196)
|
(196)
|
(209)
|
(185)
|
(118)
|
(12)
|
90
|
145
|
181
|
162
|
132
|
(76)
|
(165)
|
(232)
|
(287)
|
(210)
|
(231)
|
(279)
|
(292)
|
(272)
|
(264)
|
(217)
|
(238)
|
|
Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Net Income (Common) |
(54)
N/A
|
(70)
-30%
|
(86)
-23%
|
(73)
+16%
|
(87)
-20%
|
(103)
-18%
|
(137)
-33%
|
(200)
-46%
|
(223)
-12%
|
(248)
-11%
|
(259)
-5%
|
(104)
+60%
|
(127)
-23%
|
(137)
-7%
|
(122)
+11%
|
(265)
-117%
|
(238)
+10%
|
(208)
+13%
|
(196)
+6%
|
(196)
+0%
|
(209)
-7%
|
(185)
+12%
|
(118)
+36%
|
(12)
+90%
|
90
N/A
|
145
+62%
|
181
+24%
|
162
-11%
|
132
-18%
|
(76)
N/A
|
(165)
-117%
|
(232)
-40%
|
(287)
-24%
|
(210)
+27%
|
(231)
-10%
|
(279)
-21%
|
(292)
-5%
|
(272)
+7%
|
(264)
+3%
|
(217)
+18%
|
(238)
-10%
|
|
EPS (Diluted) |
-1.68
N/A
|
-2.19
-30%
|
-2.7
-23%
|
-2.18
+19%
|
-10.64
-388%
|
-3.07
+71%
|
-3.62
-18%
|
-5.2
-44%
|
-6.01
-16%
|
-6.34
-5%
|
-6.36
0%
|
-2.01
+68%
|
-3.04
-51%
|
-2.8
+8%
|
-2.38
+15%
|
-4.89
-105%
|
-4.48
+8%
|
-3.45
+23%
|
-3.06
+11%
|
-2.88
+6%
|
-3.22
-12%
|
-2.66
+17%
|
-1.61
+39%
|
-0.15
+91%
|
1.23
N/A
|
1.95
+59%
|
2.03
+4%
|
1.84
-9%
|
1.58
-14%
|
-1.04
N/A
|
-2.18
-110%
|
-2.93
-34%
|
-3.81
-30%
|
-2.73
+28%
|
-2.98
-9%
|
-3.6
-21%
|
-3.76
-4%
|
-3.42
+9%
|
-3.02
+12%
|
-2.22
+26%
|
-2.53
-14%
|